UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$834M |
| 2 |
Alibaba
BABA
|
+$559M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$557M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$459M |
| 5 |
Stellantis
STLA
|
+$454M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$828M |
| 2 |
Apple
AAPL
|
+$800M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$654M |
| 4 |
Boeing
BA
|
+$592M |
| 5 |
JPMorgan Chase
JPM
|
+$416M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.37% |
| 2 | Healthcare | 6.89% |
| 3 | Financials | 5.79% |
| 4 | Consumer Discretionary | 5.66% |
| 5 | Communication Services | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Ascendis Pharma A/S
ASND
$16.7B
| $1.2M | ﹤0.01% |
10,683
-3,220
| -23% | -$418K |
|
|
SABA
3202
Saba Capital Income & Opportunities Fund II
SABA
$222M
| $1.2M | ﹤0.01% |
112,131
-37,703
| -25% | -$443K |
|
3203
PUT
Cardinal Health
CAH
$55.8B
| $1.2M | ﹤0.01% |
25,000
| – | – |
|
3204
Akebia Therapeutics
AKBA
$241M
| $1.19M | ﹤0.01% |
157,487
-65,089
| -29% | -$506K |
|
3205
Apogee Enterprises
APOG
$899M
| $1.19M | ﹤0.01% |
57,362
-35,638
| -38% | -$1.04M |
|
3206
Greif
GEF
$4.99B
| $1.19M | ﹤0.01% |
38,346
-35,107
| -48% | -$1.33M |
|
|
NBL
3207
DELISTED
Noble Energy, Inc.
NBL
| $1.19M | ﹤0.01% |
197,092
-47,831
| -20% | -$767K |
|
3208
Quince Therapeutics
QNCX
$30.3M
| $1.19M | ﹤0.01% |
130
-5
| -4% | -$49.4K |
|
3209
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.29B
| $1.19M | ﹤0.01% |
44,869
-13,342
| -23% | -$399K |
|
3210
First Majestic Silver
AG
$9.23B
| $1.19M | ﹤0.01% |
191,494
+119,806
| +167% | +$1.07M |
|
|
EPAY
3211
DELISTED
Bottomline Technologies Inc
EPAY
| $1.19M | ﹤0.01% |
32,357
-33,426
| -51% | -$1.54M |
|
3212
NETSCOUT
NTCT
$2.81B
| $1.18M | ﹤0.01% |
50,023
-98,477
| -66% | -$2.5M |
|
3213
Simmons First National
SFNC
$3.43B
| $1.18M | ﹤0.01% |
64,359
-12,916
| -17% | -$293K |
|
|
REGI
3214
DELISTED
Renewable Energy Group, Inc.
REGI
| $1.18M | ﹤0.01% |
57,643
+47,759
| +483% | +$1.21M |
|
3215
VanEck Short Muni ETF
SMB
$314M
| $1.18M | ﹤0.01% |
68,008
+4,207
| +7% | +$74.4K |
|
|
KDMN
3216
DELISTED
Kadmon Holdings, Inc.
KDMN
| $1.18M | ﹤0.01% |
282,203
+80,332
| +40% | +$346K |
|
|
BTO
3217
John Hancock Financial Opportunities Fund
BTO
$807M
| $1.18M | ﹤0.01% |
64,385
-8,700
| -12% | -$258K |
|
3218
Upbound Group
UPBD
$1.12B
| $1.18M | ﹤0.01% |
83,543
-32,124
| -28% | -$773K |
|
3219
China Yuchai International
CYD
$1.77B
| $1.18M | ﹤0.01% |
109,495
-3,715
| -3% | -$44.5K |
|
3220
iShares JPMorgan EM Corporate Bond ETF
CEMB
$412M
| $1.18M | ﹤0.01% |
26,168
+3,830
| +17% | +$194K |
|
3221
UMB Financial
UMBF
$11.3B
| $1.18M | ﹤0.01% |
25,364
-57,505
| -69% | -$3.5M |
|
|
EGOV
3222
DELISTED
NIC Inc
EGOV
| $1.18M | ﹤0.01% |
51,137
-64,705
| -56% | -$1.32M |
|
3223
Macerich
MAC
$6.87B
| $1.17M | ﹤0.01% |
208,056
+24,150
| +13% | +$481K |
|
3224
National Beverage
FIZZ
$2.87B
| $1.17M | ﹤0.01% |
54,860
-102,394
| -65% | -$2.24M |
|
3225
Darling Ingredients
DAR
$9.97B
| $1.17M | ﹤0.01% |
61,015
-122,050
| -67% | -$3.09M |
|
Similar funds
UBS Group's Q1 2020 Portfolio in Review
As of Q1 2020, UBS Group held 8,948 positions worth $212B, down 26% from $287B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
UBS Group withdrew a net $21.6B in Q1 2020, closing 880 positions and reducing 4,775 holdings. Its most notable exit was Wellcare Health Plans, Inc., an estimated $196M position sold in full.
By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.8% a quarter earlier, followed by Healthcare and Financials.
Against the trend, UBS Group opened a new position in VelocityShares Daily 2x VIX Short Term ETN worth $221M.
- UBS Group's largest Q1 2020 buy was VelocityShares Daily 2x VIX Short Term ETN: 705,722 shares worth $221M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $834M increase.
- UBS Group's biggest Q1 2020 reduction was Microsoft, cutting an estimated $828M.
- UBS Group fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $196M.
- UBS Group's ten largest holdings make up 17% of its $212B portfolio in Q1 2020.
- UBS Group opened 748 new positions and closed 880 in Q1 2020.
- UBS Group's portfolio value fell 26% quarter-over-quarter to $212B.
Based on UBS Group's 13F filing for Q1 2020, filed 1 May 2020.